Related references
Note: Only part of the references are listed.A review of the history, properties, and use of the immunomodulatory compound lenalidomide
Jerome B. Zeldis et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALIST CANDIDATES OF THE PRIX GALIEN USA, INTERNATIONAL, AND PRO BONO HUMANITARIAN AWARDS 2010 (2011)
Functional modulation of AMP-activated protein kinase by cereblon
Kwang Min Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
IMiD immunomodulatory compounds block C/EBPβ translation through eIF4E down-regulation resulting in inhibition of MM
Shirong Li et al.
BLOOD (2011)
Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
Yuan Xiao Zhu et al.
BLOOD (2011)
Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response
Antonia Lopez-Girona et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Lenalidomide Restrains Motility and Overangiogenic Potential of Bone Marrow Endothelial Cells in Patients with Active Multiple Myeloma
Annunziata De Luisi et al.
CLINICAL CANCER RESEARCH (2011)
Pomalidomide therapy for myeloma
Stephen Schey et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
mRNA distribution of the thalidomide binding protein cereblon in adult mouse brain
Miho Aizawa et al.
NEUROSCIENCE RESEARCH (2011)
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma
Guellue Goerguen et al.
BLOOD (2010)
Recent advances of IMiDs in cancer therapy
Shirong Li et al.
CURRENT OPINION IN ONCOLOGY (2010)
Temporal and Spatial Mouse Brain Expression of Cereblon, An Ionic Channel Regulator Involved in Human Intelligence
Joseph J. Higgins et al.
JOURNAL OF NEUROGENETICS (2010)
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito et al.
SCIENCE (2010)
Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases
Yibing Xu et al.
BLOOD (2009)
Pomalidomide and Lenalidomide Induce p21WAF-1 Expression in Both Lymphoma and Multiple Myeloma through a LSD1-Mediated Epigenetic Mechanism
Laure Escoubet-Lozach et al.
CANCER RESEARCH (2009)
Cereblon is expressed in the retina and binds to voltage-gated chloride channels
Bettina Hohberger et al.
FEBS LETTERS (2009)
Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma
Martha Q. Lacy et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions
Ling Lu et al.
MICROVASCULAR RESEARCH (2009)
Dysregulation of large-conductance Ca2+-activated K+ channel expression in nonsyndromal mental retardation due to a cereblon p.R419X mutation
Joseph J. Higgins et al.
NEUROGENETICS (2008)
Primary function analysis of human mental retardation related gene CRBN
Wang Xin et al.
MOLECULAR BIOLOGY REPORTS (2008)
Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis
Nionhang Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells
Dominique Verhelle et al.
CANCER RESEARCH (2007)
Properties of thalidomide and its analogues: Implications for anticancer therapy
SK Teo
AAPS JOURNAL (2005)
Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain
S Jo et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Timeline - The evolution of thalidomide and its IMiD derivatives as anticancer agents
JB Bartlett et al.
NATURE REVIEWS CANCER (2004)
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects
K Dredge et al.
BRITISH JOURNAL OF CANCER (2002)
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
FE Davies et al.
BLOOD (2001)
Share Paper
